Radboud University Nijmegen Medical Centre
Nijmegen, 6500 HB, Netherlands
NCT Number: NCT01660828
Strenuous exercise in apparent healthy individuals increases plasma (high sensitive) troponin levels. The underlying mechanism is not yet elucidated, but could be explained by changes due to a mismatch in oxygen demand and supply that mimic those of ischemia and reperfusion injury. If the mechanism underlying the troponin release during exercise is similar to that of ischemia reperfusion injury (IRI), than it should be susceptible to remote ischemic preconditioning (RIPC) as RIPC is a well validated technique to reduce IRI. To test this hypothesis healthy volunteers underwent a strenuous exercise test with or without preceding RIPC.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Nijmegen, 6500 HB, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
RIPC protocol which consist of three 5-min cycles of bilateral forearm ischemia
Time frame: timepoints t= baseline, 0, 1, 2, 3,4 and 8 hours after finishing exercise
serum level of high sensitive troponin in response to intensive exercise test with or without RIPC at several timepoints
Radboud University Medical Center
Other
The Effect of Remote Ischemic Preconditioning on Plasma Troponin I Appearance After a Standardized Cycling Test in Healthy Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01438723
Cardiovascular Disease, Cardiovascular Diseases
Nijmegen, Gelderland, Netherlands
View Trial DetailsNCT01295567
Cardiovascular Disease, Cardiovascular Diseases
Nijmegen, Netherlands
View Trial DetailsNCT00441597
Cardiovascular Disease, Cardiovascular Diseases
Nijmegen, Netherlands
View Trial DetailsNCT00430170
Cardiovascular Disease, Cardiovascular Diseases
Nijmegen, Netherlands
View Trial Details